OncoCare
Cancer in older adults, especially those occurring in individuals aged 65 years or older, presents unique considerations. And while the risk of cancers increases with age, the suitability of cancer treatments, like chemotherapy, surgery or radiation therapy, must be carefully evaluated based on older adults' health, fitness and psychosocial circumstances.
In this blog, we delve into cancer in older adults and cancer treatment options, addressing concerns and offering insights for informed decisions.
A notable trend in recent years is the increase in life expectancy, due to advancements in healthcare, improved living conditions, and better access to medical care. While this is undoubtedly positive news, it also brings to light the challenges associated with an ageing population, including a higher incidence of cancer.
As we grow older, our likelihood of developing cancer increases, a fact that may come as a surprise to many, given the frequent media focus on cancer in younger populations. However, it is far less common for younger individuals to be diagnosed with cancer.
In fact, according to the Singapore Cancer Registry Annual Report 2021, the landscape of cancer diagnoses has shifted dramatically over several decades. From 1968-1972 to 2017-2021, there was a noticeable decline in cancer diagnoses among younger age groups, whereas diagnoses among the elderly groups saw a significant rise. Specifically, the proportion of individuals diagnosed with cancer at the age of 70 and above doubled from 16.3% to 39.2%. Additionally, the median age at diagnosis increased from 58.7 years to 66.4 years.
This shift is reflected in the patterns of the most common cancers. For instance:
This demographic shift has significant implications for healthcare systems. It highlights the need for increased emphasis on geriatric oncology and the development of personalised treatment strategies that address the unique needs and circumstances of older adults.
As individuals age, their risk of developing cancer increases due to various factors, such as cumulative exposure to environmental toxins, genetic predisposition, and age-related changes in the body's cells.
In general, the ageing process naturally leads to the accumulation of cellular damage. This damage often arises spontaneously from normal metabolic processes or from external sources like tobacco smoke, excessive alcohol consumption, and UV radiation exposure.
Our bodies are typically adept at repairing cellular damage or triggering the self-destruction of damaged cells. However, over time, with age, the efficiency of these repair mechanisms diminishes. If the cellular damage persists, these cells may begin to behave abnormally, which can sometimes lead to cancer. And the longer our cells are exposed to internal and external risk factors, the greater the likelihood of significant damage, making cancer more probable as we age.
While treatment strategies for cancer are broadly consistent across different age groups, focusing on the type and stage of cancer, older adults present specific challenges and needs that differ from those of younger patients. Therefore, it is important that cancer treatment plans are tailored for older individuals by considering their overall health, existing comorbidities, and life circumstances.
Age-related factors can significantly influence treatment decisions. Older adults may have reduced tolerance for certain cancer treatments, such as chemotherapy, and diminished reserves to respond to disease and treatment-related complications.
They are more likely to have multiple medical problems, functional limitations, and variable access to transportation, social support, and financial resources. Balancing one’s quality of life and life expectancy becomes a crucial consideration for both older adults and their caregivers. Older adults are 11 times more likely to develop cancer in comparison to younger people, and approximately 60% of all cancer patients are 65 and older, it’s essential to learn more about how we can rationalise the use of the different types of cancer treatment in older adults.
Cancer treatment encompasses a range of approaches, from traditional therapies like chemotherapy and radiation to other methods such as targeted therapies and immunotherapy.
Chemotherapy is a common cancer treatment that uses drugs to eliminate cancer cells. It can be given orally or through the veins, targeting cancer cells throughout the body. Depending on the stage and type of cancer, chemotherapy may be used alone or in combination with surgery or radiation therapy. In older adults with cancer, the decision to undergo chemotherapy takes into account the patient's overall health, functional status, and specific cancer characteristics.
Older adults are more likely to have other factors which may contribute to their overall health status. Therefore, when assessing an older adult’s suitability for chemotherapy, several unique factors should be carefully considered, such as:
Radiation therapy uses beams of intense energy to destroy cancer cells. It can be used alone or in combination with other treatments like surgery or chemotherapy.
For older adults, radiation therapy is often an option due to its non-invasive nature and minimal impact on the body as a whole. However, it's essential to consider potential side effects and discuss them with your doctor. Factors to consider include managing any existing health conditions, the demands of the treatment schedule, and ensuring adequate support to maintain independence.
Targeted therapy uses drugs or other substances to specifically target and attack cancer cells while minimising damage to healthy cells. This approach can be used alone or with other treatments like chemotherapy, surgery, or radiation therapy.
And while targeted therapies are generally safe and effective for older adults, dosage adjustments may be necessary to ensure the best outcome.
Immunotherapy harnesses the body's own immune system to fight cancer. It works by stimulating or modifying the immune system to identify and eliminate cancer cells.
And while it is generally safe for older adults, studies suggest that they may experience slightly more side effects and may discontinue treatment earlier than younger patients. This highlights the importance of close monitoring and individualised care for older adults receiving immunotherapy.
Hormone-sensitive cancers, like breast cancer, rely on hormones to grow. Hormone therapy aims to block or reduce hormone levels in the body, thus slowing or stopping cancer growth.
This treatment can be highly beneficial for older adults, as it is often as effective as chemotherapy but with fewer side effects. However, it's important to note that hormone therapy may not always provide a significant survival advantage in older patients.
While treatment needs to be adapted to individual health profiles, and several factors must be considered before deciding on a specific treatment route, the potential benefits are significant. This is because appropriate cancer treatment is crucial for preventing the spread of cancer, slowing tumour growth, and targeting cancer cells that have metastasized in older adults.
It's important to recognise that cancer treatment can be beneficial for patients of any age. Additionally, advancements in cancer treatments, including chemotherapy, have demonstrated substantial benefits for older adults.
Studies have shown that targeted therapies, such as immunotherapy and molecularly targeted agents, can improve survival rates and quality of life for older adults with cancer. These treatments are designed to specifically target cancer cells while minimising damage to healthy tissues, thereby reducing the side effects commonly associated with traditional chemotherapy. These are more improved therapeutic options for older adults with cancer, offering them a better quality of life and improved overall outcomes.
It is still important to acknowledge the potential risks and side effects of cancer treatment, particularly in older adults with reduced physiologic reserves. Factors such as coexisting medical conditions, multiple medications, bone marrow changes, and other physical alterations can influence how cancer treatment affects older adults. Additionally, cognitive problems, including difficulties with thinking and memory, may impact treatment decisions. The decision to pursue cancer treatment should be a collaborative process, considering the potential benefits, weighing them against the risks, and taking into account the individual's state of health, goals and preferences.
There is increased awareness about the need to develop age-appropriate screening protocols, refine treatment strategies, and improve supportive care for older adults with cancer. These efforts would provide holistic cancer care to ensure optimal treatment outcomes while maintaining the quality of life in older adults.
However, despite these benefits, older adults may face a range of psychosocial challenges when making cancer-related treatment decisions.
These diverse factors highlight the complex interplay between psychosocial factors that can influence geriatric patients' decisions regarding cancer treatment and their willingness to pursue it.
While the focus often falls on older individuals, especially when it comes to financial constraints, financial aid from programmes like the Cancer Care Fund extends to cancer patients of all ages facing economic hardships soon after diagnosis. This fund is particularly aimed at Singaporeans or Permanent Residents, although non-residents with close familial ties to Singaporeans or Permanent Residents who have lived in Singapore for at least five years may also apply. Beneficiaries must be newly diagnosed within the first six months and must align with the income stipulations of the Blue/Orange Community Health Assist Scheme (CHAS).
The Cancer Treatment Fund further supports by subsidising part of the cancer treatment costs for patients in need. And eligibility extends to patients treated in subsidised wards of restructured hospitals, meeting both medical and means-test criteria set by the Singapore Cancer Society (SCS). Approved applicants can receive treatment subsidies up to 100% or $6,000 per treatment cycle, capped at $50,000 per individual.
But, of course, prevention is always better than cure. While cancer can impact anyone, certain lifestyle choices can significantly lower your risk, irrespective of your age.
Here’s how you can proactively safeguard your health:
When it comes to cancer in older adults, consulting doctors in Singapore experienced with treating cancer in older adults, such as OncoCare, is crucial. Our oncology consultants have knowledge of managing cancer in older individuals and can provide personalised evaluation and guidance. If you or your loved one is facing the possibility of chemotherapy, it's important to consider the unique circumstances that come with cancer in older adults. Consulting with a cancer specialist will help you better understand the specific benefits and risks associated with chemotherapy in older adults. By involving healthcare providers and support networks, you can ensure that your decisions are personalised and well-informed.
At OncoCare, we embrace the opportunity to provide personalised cancer care that empowers older adults to thrive during their golden years. Our dedicated team is committed to ensuring that you receive the appropriate treatment while preserving your quality of life. Don't hesitate to reach out to us for compassionate and tailored assistance from our expert cancer specialists. Together, we can navigate the path to a brighter and healthier future.
“Expert knowledge means better care for cancer”
Written by:
Dr Angela Pang
MBBS (Singapore)
Grad Dip (GRM)
MRCP (UK)
M Med (Internal Med)
Site Map | PDPA | Terms of Use | Disclaimer |
Contact Us | Career | Media Contact